Renalytix Plc Stock
Stocks
RENX
GB00BYWL4Y04
Advanced Medical Equipment & Technology
OTC Markets Traded|
Delayed
London S.E.
06:07:44 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 5.510 GBX | -1.61% |
|
-5.00% | -6.61% |
| 10-28 | Renalytix Plc Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 10-28 | Earnings Flash (RENX.L) Renalytix plc Reports FY26 Revenue $3.0M | MT |
| Market Cap | 13.34M 11.97M 11.06M 10.02M 18.72M 1.27B 18.94M 132M 52.68M 665M 50.05M 48.99M 2.11B | P/E 2024 |
-0.45x | P/E 2025 | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 17.94M 16.09M 14.88M 13.47M 25.17M 1.71B 25.48M 178M 70.85M 894M 67.31M 65.89M 2.84B | EV / Sales 2024 |
11,059,330x | EV / Sales 2025 | 12,499,418x |
| Free-Float |
81.69% | Yield 2024 * |
-
| Yield 2025 | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| RENX | Delayed | |
OTC Markets
| RENXF | Delayed | |
|
Deutsche Boerse AG
| 2O9 | Delayed | |
|
Börse Stuttgart
| 2O9 | Delayed | |
|
Boerse Muenchen
| 2O9 | Real-time |
Last Transcript: Renalytix Plc
| 1 day | -1.61% | ||
| 1 week | -5.00% | ||
| Current month | -9.67% | ||
| 1 month | -8.93% | ||
| 3 months | +107.92% | ||
| 6 months | +206.11% | ||
| Current year | -6.61% |
| 1 week | 5.15 |  | 6.1 |
| 1 month | 5.1 | | 6.3 |
| Current year | 1.6 | | 6.57 |
| 1 year | 1.6 | | 8.4 |
| 3 years | 1.6 | | 74.9 |
| 5 years | 1.6 | | 909.7 |
| 10 years | 1.6 | | 1,220 |
| Manager | Title | Age | Since |
|---|---|---|---|
James McCullough
CEO | Chief Executive Officer | 58 | 2018-03-14 |
Joel Jung
DFI | Director of Finance/CFO | 68 | 2024-05-27 |
Howard Doran
PSD | President | 65 | 2024-04-29 |
| Director | Title | Age | Since |
|---|---|---|---|
James McCullough
BRD | Director/Board Member | 58 | 2018-03-14 |
| Chairman | 74 | - | |
Fergus Fleming
BRD | Director/Board Member | 59 | 2018-03-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/13/26 | Buy | Founder | 250 | 0.0001% | ||
| 2/13/26 | Buy | Chief Financial Officer | 500 | 0.0001% | ||
| 2/13/26 | Buy | Founder | 500 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.61% | -5.00% | -33.21% | -87.04% | 45.01M | |
| +1.61% | +1.46% | +26.28% | +63.22% | 260B | |
| +0.89% | +0.09% | +7.92% | +24.58% | 165B | |
| -0.38% | +3.75% | -18.56% | +71.51% | 154B | |
| -5.84% | -4.67% | -57.98% | -14.32% | 61.49B | |
| +1.06% | +3.82% | +11.67% | +48.73% | 52.9B | |
| +0.55% | +2.63% | -13.15% | -6.36% | 52.84B | |
| +1.39% | -0.85% | +9.09% | +67.70% | 51.46B | |
| +2.25% | +2.10% | +24.43% | +76.59% | 51.16B | |
| +1.78% | +4.24% | +37.85% | +94.84% | 46.85B | |
| Average | +0.06% | +1.67% | -0.57% | +33.95% | 89.58B | |
| Weighted average by Cap. | +0.43% | +1.41% | +5.73% | +49.93% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.29 2.05 1.9 1.72 3.21 218.01 3.25 22.7 9.04 114.08 8.59 8.41 362.16 | 3 2.69 2.49 2.25 4.21 285.72 4.26 29.75 11.85 149.51 11.26 11.02 474.65 |
| Net income | -33.46M -30.02M -27.75M -25.13M -46.96M -3.19B -47.52M -332M -132M -1.67B -126M -123M -5.29B | -20.4M -18.3M -16.92M -15.33M -28.63M -1.94B -28.98M -202M -80.59M -1.02B -76.55M -74.94M -3.23B |
| Net Debt | 3.86M 3.46M 3.2M 2.9M 5.41M 367M 5.48M 38.23M 15.23M 192M 14.47M 14.16M 610M | 4.6M 4.13M 3.82M 3.46M 6.46M 438M 6.53M 45.62M 18.17M 229M 17.26M 16.9M 728M |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | GBX 5.510 | -1.61% | 252,022 |
| 26-10-28 | GBX 5.600 | -5.88% | 2,985,462 |
| 26-10-27 | GBX 5.950 | 0.00% | 616,207 |
| 26-10-26 | GBX 5.950 | -0.83% | 914,935 |
| 26-10-23 | GBX 6.000 | +3.45% | 2,485,415 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RENX Stock
Select your edition
All financial news and data tailored to specific country editions
